Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02487020 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Marketed |
| 02487039 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 20 MCG | Marketed |
| 02533286 | PREHEVBRIO | VBI VACCINES INC. | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Approved |
| 02561476 | RECOMBIVAX HB | MERCK CANADA INC | Solution | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 5 MCG | Marketed |
| 02245977 | RECOMBIVAX HB | MERCK CANADA INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 40 MCG | Marketed |
| 02237548 | TWINRIX JUNIOR | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG; HEPATITIS A VIRUS, INACTIVATED 360 UNIT | Marketed |
| 02296454 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Cancelled Post Market |
| 01919431 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 20 MCG | Cancelled Post Market |
| 02243676 | RECOMBIVAX HB | MERCK CANADA INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Cancelled Post Market |
| 01934023 | RECOMBIVAX HB (ADULT DIALYSIS WITH PRESERVATIVE) | MERCK CANADA INC | Solution | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 40 MCG | Cancelled Post Market |
| 00749486 | RECOMBIVAX HB (WITH PRESERVATIVE) | MERCK CANADA INC | Solution | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Cancelled Post Market |